Cutera (NASDAQ:CUTR) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research note published on Thursday morning. The firm issued a sell rating on the medical device company’s stock.

Cutera Trading Down 8.0 %

Shares of Cutera stock opened at $0.47 on Thursday. The firm has a market cap of $9.47 million, a PE ratio of -0.07 and a beta of 1.32. The stock has a 50 day moving average of $0.41 and a 200 day moving average of $0.64. Cutera has a 12 month low of $0.28 and a 12 month high of $3.10.

Cutera (NASDAQ:CUTR) last posted its earnings results on Thursday, November 7th. The medical device company reported ($1.94) EPS for the quarter, missing analysts’ consensus estimates of ($0.96) by ($0.98). The firm had revenue of $32.50 million during the quarter, compared to analysts’ expectations of $32.57 million. During the same period in the prior year, the company earned ($2.22) EPS. As a group, equities research analysts forecast that Cutera will post -5.78 earnings per share for the current fiscal year.

Institutional Trading of Cutera

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC increased its stake in Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the period. Squarepoint Ops LLC owned approximately 0.57% of Cutera worth $172,000 as of its most recent SEC filing. 90.70% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.